HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yuki Ozaki Selected Research

TEMPOL-H

11/2013Redox nanoparticle therapeutics to cancer--increase in therapeutic effect of doxorubicin, suppressing its adverse effect.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yuki Ozaki Research Topics

Disease

15Neoplasms (Cancer)
05/2022 - 11/2013
14Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2015
10Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 04/2018
6Schizophrenia (Dementia Praecox)
08/2020 - 08/2014
5Lung Neoplasms (Lung Cancer)
09/2021 - 02/2018
5Cognitive Dysfunction
01/2021 - 01/2015
4Adenocarcinoma
07/2021 - 01/2015
4Adenocarcinoma of Lung
01/2021 - 02/2018
3Dementia (Dementias)
01/2021 - 10/2016
3Neoplasm Metastasis (Metastasis)
01/2021 - 09/2020
3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2015
2Infections
01/2022 - 01/2021
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2021 - 01/2020
2Disease Progression
01/2021 - 01/2017
2Major Depressive Disorder (Major Depressive Disorders)
01/2021 - 08/2020
2Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2021
2Necrosis
12/2020 - 01/2015
2Prostatic Neoplasms (Prostate Cancer)
01/2015 - 01/2014
1Hypertension (High Blood Pressure)
06/2022
1Paraganglioma (Paragangliomas)
06/2022
1Tertiary Lymphoid Structures
05/2022
1COVID-19
12/2021
1Melanoma (Melanoma, Malignant)
03/2021
1Malignant Mesothelioma
01/2021
1Cysts
01/2021
1Lymphoma (Lymphomas)
01/2021
1Pneumonia (Pneumonitis)
01/2021
1Edema (Dropsy)
09/2020
1Carcinoma (Carcinomatosis)
09/2020
1Mood Disorders (Mood Disorder)
08/2020
1Bipolar Disorder (Manic Depressive Psychosis)
08/2020
1Hypokinesia (Bradykinesia)
01/2020
1Diabetes Mellitus
10/2019
1Myasthenia Gravis
10/2019
1Thrombocytopenia (Thrombopenia)
10/2019
1Hemorrhage
10/2019
1Cerebral Infarction
10/2019
1Alveolar Bone Loss
01/2017
1Periodontitis
01/2017
1Mitochondrial Diseases (Mitochondrial Disease)
01/2017
1Synucleinopathies
10/2016

Drug/Important Bio-Agent (IBA)

13Messenger RNA (mRNA)IBA
01/2021 - 01/2015
10Biomarkers (Surrogate Marker)IBA
09/2021 - 01/2015
4Immune Checkpoint InhibitorsIBA
09/2021 - 10/2019
4ErbB Receptors (EGF Receptor)IBA
07/2021 - 02/2018
3LigandsIBA
01/2021 - 10/2019
3NivolumabIBA
01/2021 - 10/2019
2Therapeutic UsesIBA
01/2022 - 11/2013
2B7-H1 AntigenIBA
03/2021 - 12/2020
2Bevacizumab (Avastin)FDA Link
01/2021 - 09/2020
2Phosphotransferases (Kinase)IBA
01/2021 - 01/2014
2Tyrosine Kinase InhibitorsIBA
09/2020 - 06/2020
2Pharmaceutical PreparationsIBA
01/2020 - 01/2017
2GhrelinIBA
01/2019 - 12/2018
2Neuroprotective AgentsIBA
12/2018 - 07/2012
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2015 - 07/2012
2PolymersIBA
01/2015 - 07/2012
1Doxazosin (Cardura)FDA LinkGeneric
06/2022
1A-factor (Streptomyces)IBA
05/2022
1EpitopesIBA
12/2021
1IpilimumabIBA
12/2021
1MucinsIBA
09/2021
1CateninsIBA
03/2021
1Vesicular Transport Adaptor ProteinsIBA
01/2021
1brigatinibIBA
01/2021
11-methyl-1-piperidinomethane sulfonateIBA
01/2021
1claudin 15IBA
01/2021
1alectinibIBA
01/2021
1ceritinibIBA
01/2021
1Pemetrexed (MTA)FDA Link
01/2021
1Monoclonal AntibodiesIBA
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
01/2021
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2021
1PlatinumIBA
01/2021
1lorlatinibIBA
01/2021
1Amyloid beta-PeptidesIBA
12/2020
1Docetaxel (Taxotere)FDA Link
12/2020
1Adenosine Triphosphate (ATP)IBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2020
1AntibodiesIBA
10/2019
1SteroidsIBA
10/2019
1Ghrelin ReceptorsIBA
01/2019
1Dopamine Receptors (Dopamine Receptor)IBA
01/2019
1Complementary DNA (cDNA)IBA
02/2018
1Peptides (Polypeptides)IBA
01/2017
1Apolipoproteins E (ApoE)IBA
01/2017
1ApolipoproteinsIBA
01/2017
1Amyloid (Amyloid Fibrils)IBA
10/2016
1SynucleinsIBA
10/2016
1Proteins (Proteins, Gene)FDA Link
10/2016
1alpha-SynucleinIBA
10/2016
1Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
01/2016

Therapy/Procedure

5Therapeutics
09/2021 - 11/2013
4Drug Therapy (Chemotherapy)
01/2021 - 11/2013
1Transjugular Intrahepatic Portasystemic Shunt
06/2022
1Blood Transfusion (Blood Transfusions)
07/2021
1Radioimmunotherapy
01/2021
1Radiotherapy
09/2020
1Pneumonectomy (Lung Volume Reduction)
04/2018